Dupixent (dupilumab) now approved in European Union for severe chronic rhinosinusitis with nasal polyposis Read more
Exclusive interview with conference speaker Che Connon released ahead of SMi’s Ophthalmic Drugs Conference Read more
GSK starts a phase III clinical programme for a potential first-in-class antibiotic, gepotidacin Read more
Ziopharm Oncology and MD Anderson Cancer Center Announce New R&D Agreement to Expand TCR-T Program Read more
CARsgen Announces Investigational CAR-T Therapy CT053 Granted RMAT Designation by the FDA for R/R Multiple Myeloma Read more
Gilead and Glympse Bio Announce Strategic Collaboration for Use of Biomarker Technology in NASH Clinical Development Read more